Long-term safety and efficacy of dolutegravir and unboosted atazanavir among experienced HIV-infected adults

AIDS. 2019 Dec 1;33(15):2446-2447. doi: 10.1097/QAD.0000000000002365.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Atazanavir Sulfate
  • HIV Infections*
  • HIV Protease Inhibitors*
  • HIV-1*
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Oxazines
  • Piperazines
  • Pyridones
  • Viral Load

Substances

  • HIV Protease Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • Atazanavir Sulfate
  • dolutegravir